Eleison to Partner China Oncology Focus an Affiliate of Lee’s for Glufosfamide
21 Nov 2017 //
PRESS RELEASE
Eleison Announces Approval from CFDA to Expand Eleison’s PhIII Glufosfamide
16 May 2016 //
PRESS RELEASE
Eleison Announces the Issuance of New Patents for Glufosfamide and ILC
11 Dec 2015 //
PRESS RELEASE
Eleison Announces Successful Completion of Stage 1 of its Phase II Trial of ILC
01 May 2015 //
PRESS RELEASE
Eleison Announces Agreement with FDA on a SPA for a Ph3 Glufosfamide
26 May 2010 //
PRESS RELEASE
Threshold Pharmaceuticals Licenses Glufosfamide to Eleison Pharmaceuticals
15 Oct 2009 //
PRESS RELEASE